A359090 logo

C&R Research Inc. Stock Price

KOSDAQ:A359090 Community·₩46.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A359090 Share Price Performance

₩814.00
-271.00 (-24.98%)
₩814.00
-271.00 (-24.98%)
Price ₩814.00

A359090 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks
1 Reward

C&R Research Inc. Key Details

₩64.0b

Revenue

₩0

Cost of Revenue

₩64.0b

Gross Profit

₩61.2b

Other Expenses

₩2.8b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
48.71
100.00%
4.38%
9.6%
View Full Analysis

About A359090

Founded
1997
Employees
510
CEO
Moontae Yoon
WebsiteView website
www.cnrres.com

C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices. The company’s therapeutic area comprises oncology, cardiovascular, endocrinology, dermatology, central nervous system, ophthalmology, and rare disease.The company was founded in 1997 and is based in Seoul, South Korea.

Recent A359090 News & Updates

Recent updates

No updates